Analysis of variants in DNA damage signalling genes in bladder cancer

BackgroundChemicals from occupational exposure and components of cigarette smoke can cause DNA damage in bladder urothelium. Failure to repair DNA damage by DNA repair proteins may result in mutations leading to genetic instability and the development of bladder cancer. Immunohistochemistry studies have shown DNA damage signal activation in precancerous bladder lesions which is lost on progression, suggesting that the damage signalling mechanism acts as a brake to further tumorigenesis. Single nucleotide polymorphisms (SNPs) in DSB signalling genes may alter protein function. We hypothesized that SNPs in DSB signalling genes may modulate predisposition to bladder cancer and influence the effects of environmental exposures.MethodsWe recruited 771 cases and 800 controls (573 hospital-based and 227 population-based from a previous case-control study) and interviewed them regarding their smoking habits and occupational history. DNA was extracted from a peripheral blood sample and genotyping of 24 SNPs in MRE11, NBS1, RAD50, H2AX and ATM was undertaken using an allelic discrimination method (Taqman).ResultsSmoking and occupational dye exposure were strongly associated with bladder cancer risk. Using logistic regression adjusting for age, sex, smoking and occupational dye exposure, there was a marginal increase in risk of bladder cancer for an MRE11 3'UTR SNP (rs2155209, adjusted odds ratio 1.54 95% CI (1.13–2.08, p = 0.01) for individuals homozygous for the rare allele compared to those carrying the common homozygous or heterozygous genotype). However, in the hospital-based controls, the genotype distribution for this SNP deviated from Hardy-Weinberg equilibrium. None of the other SNPs showed an association with bladder cancer and we did not find any significant interaction between any of these polymorphisms and exposure to smoking or dye exposure.ConclusionApart from a possible effect for one MRE11 3'UTR SNP, our study does not support the hypothesis that SNPs in DSB signaling genes modulate predisposition to bladder cancer.

[1]  Michel Nussenzweig,et al.  H2AX: the histone guardian of the genome. , 2004, DNA repair.

[2]  J. Barrett,et al.  The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder , 2005, British Journal of Cancer.

[3]  R. Verdun,et al.  Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. , 2005, Molecular cell.

[4]  Paul D P Pharoah,et al.  Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.

[5]  H. Niida,et al.  Genetic instability in cancer cells by impaired cell cycle checkpoints , 2006, Cancer science.

[6]  Z. Darżynkiewicz,et al.  Constitutive Histone H2AX Phosphorylation and ATM Activation, the Reporters of DNA Damage by Endogenous Oxidants , 2006, Cell cycle.

[7]  Margaret R Karagas,et al.  Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. , 2006, Carcinogenesis.

[8]  R. Cartwright,et al.  Occupational bladder cancer and cigarette smoking in West Yorkshire. , 1981, British journal of urology.

[9]  H. Soliman,et al.  Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract , 2006, Oncogene.

[10]  A. Ashworth,et al.  Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. , 2007, Human molecular genetics.

[11]  D. Campa,et al.  Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. , 2006, Carcinogenesis.

[12]  R. Doll,et al.  Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors , 1994, BMJ.

[13]  X. Shu,et al.  Two-stage case-control study of common ATM gene variants in relation to breast cancer risk , 2007, Breast Cancer Research and Treatment.

[14]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[15]  H. Niida,et al.  DNA damage checkpoints in mammals. , 2006, Mutagenesis.

[16]  R. Millikan,et al.  Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. , 2006, American journal of human genetics.

[17]  K. Hemminki,et al.  Single nucleotide polymorphisms in breast cancer. , 2004, Oncology reports.

[18]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[19]  N. Malats,et al.  Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[20]  K. Hemminki,et al.  Polymorphisms in DNA repair and metabolic genes in bladder cancer. , 2003, Carcinogenesis.

[21]  Zhenzhong Zhang,et al.  Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[22]  Debra Silverman,et al.  Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. , 2007, Carcinogenesis.

[23]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Jolanta Lissowska,et al.  DNA repair and cell cycle control genes and the risk of young-onset lung cancer. , 2006, Cancer research.

[25]  I. M. Jones,et al.  Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. , 2003, Mutation research.

[26]  A. Franchitto,et al.  Werner Syndrome Protein and the MRE11 Complex are Involved in a Common Pathway of Replication Fork Recovery , 2004, Cell cycle.

[27]  R. Cartwright,et al.  Cigarette smoking and bladder cancer: an epidemiological inquiry in West Yorkshire. , 1983, Journal of epidemiology and community health.

[28]  Christopher I Amos,et al.  Genetic susceptibility to lung cancer: the role of DNA damage and repair. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[30]  D. Miller,et al.  Urinary Bladder Cancer , 2002, Clinical obstetrics and gynecology.

[31]  M. Blasco,et al.  Telomeric sequences, radiation sensitivity and genomic instability , 2001, International journal of radiation biology.

[32]  S. Cohen,et al.  Epidemiology and etiology of bladder cancer. , 1992, Seminars in surgical oncology.

[33]  Y. Pommier,et al.  Defective Mre11-dependent Activation of Chk2 by Ataxia Telangiectasia Mutated in Colorectal Carcinoma Cells in Response to Replication-dependent DNA Double Strand Breaks* , 2006, Journal of Biological Chemistry.

[34]  K. Siegmund,et al.  A case-control study of cyclin D1 CCND1 870A-->G polymorphism and bladder cancer. , 2003, Carcinogenesis.

[35]  S. Chanock,et al.  Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. , 2005, Lung cancer.

[36]  Jiri Bartek,et al.  Cell-cycle checkpoints and cancer , 2004, Nature.

[37]  L. Palmer,et al.  The effect of missing data on linkage disequilibrium mapping and haplotype association analysis in the GAW14 simulated datasets , 2005, BMC Genetics.

[38]  R Doll,et al.  Mortality in relation to smoking: 40 years' observations on male British doctors , 1994, BMJ.

[39]  Alison M Dunning,et al.  Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk , 2007, Breast Cancer Research.

[40]  T. Habuchi,et al.  Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. , 2002, Carcinogenesis.

[41]  R C Garner,et al.  Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer. , 2003, Carcinogenesis.

[42]  Yun-Chul Hong,et al.  Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. , 2006, Human molecular genetics.

[43]  J. Barrett,et al.  Comprehensive Analysis of 22 XPC Polymorphisms and Bladder Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[44]  M. Ingelman-Sundberg,et al.  3'-UTR polymorphism in the human CYP2A6 gene affects mRNA stability and enzyme expression. , 2006, Biochemical and biophysical research communications.